Chronic Kidney Disease
A 6 variable model predicted advanced chronic kidney disease in patients with acute kidney injury.
A new online risk calculation tool predicts kidney failure odds in patients with chronic kidney disease.
Researchers found a 15% to 20% reduction in the risk of hospitalization for or death from heart failure in patients who received cardiac resynchronization therapy with defibrillator (CRT-D).
Five EKG parameters can identify chronic kidney disease patients at risk for cardiovascular death.
Patients with psoriasis should avoid long-term use of medications that are toxic to the kidneys.
The new risk score model helps clinicians weigh the benefits and risks associated with antiretroviral drugs.
Those who consumed high-acid diets appeared to face triple the risk of kidney failure compared with those who consumed low-acid diets.
An older male patient started antidepressants for neuropathy pain but developed hyponatremia as a result.
The increased risk of CKD and GN was seen in patients with both mild and severe psoriasis.
A woman complaining of seeing yellow lights is diagnosed with digoxin toxicity.
A new study indicated that older patients with predialysis chronic kidney disease should take statins.
Patient with back pain and blood in urine is diagnosed with autosomal dominant polycystic kidney disease.
With the advent of new treatment options, ART excluding tenofovir is beneficial for HIV-infected patients with reduced kidney function.
Patients who ate a diet of processed and fried foods, organ meats, and sweetened beverages had a 50% heightened risk of death.
In specific situations, clinicians should monitor a patient's metformin use in order to prevent dialysis and higher risk of kidney failure.
Hypertension is the leading modifiable risk factor for coronary artery disease, stroke, heart failure, and chronic kidney disease.
A history of reduced kidney function may put an individual at greater risk for developing renal and urothelial cancers.
Hypertension, obesity, diabetes and other risk factors were found in patients with chronic kidney disease years before diagnosis.
Compared with intensive home hemodialysis treatments, kidney transplant patients had better survival rates, but higher early rates of hospitalization.
Research suggests that lowering LDL has a non-significant impact on end-stage renal disease.
In which disease states or at what stages of chronic kidney disease is the HbA1c test no longer reliable?
Patients with moderate to severe psoriasis have significantly increased risk for chronic kidney disease.
The most recent guidelines from the American College of Rheumatology include pharmacologic and nonpharmacologic therapy for hyperuricemia.
All lots of the new anemia drug peginesatide have been recalled because of severe, sometimes fatal, hypersensitivity reactions.
Albuminuria levels help clinicians better stratify risk and evaluate likely outcomes.
Chronic kidney disease (CKD) could earn a spot near "previous heart attack" on the list of criteria defining people at highest risk of future coronary events.
Clinicians should be cautious when using aliskiren-containing BP medications with angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in patients with diabetes or renal impairment.
Patients with CKD who had the highest mortality tended be older, had diabetes longer and had higher BP.
Patients often have trouble understanding health outcomes they cannot see. It is our job as health-care providers to help patients understand their bodies in efforts to improve treatment compliance for chronic conditions.
Is it safe to restart osteoporosis medications in patients with stage 5 chronic kidney disease?